209 related articles for article (PubMed ID: 31753699)
1. Formation of 5α-dihydrotestosterone from 5α-androstane-3α,17β-diol in prostate cancer LAPC-4 cells - Identifying inhibitors of non-classical pathways producing the most potent androgen.
Boutin S; Roy J; Maltais R; Poirier D
Bioorg Med Chem Lett; 2020 Jan; 30(2):126783. PubMed ID: 31753699
[TBL] [Abstract][Full Text] [Related]
2. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
3. Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation.
Nunlist EH; Dozmorov I; Tang Y; Cowan R; Centola M; Lin HK
J Steroid Biochem Mol Biol; 2004 Jul; 91(3):157-70. PubMed ID: 15276623
[TBL] [Abstract][Full Text] [Related]
4. Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease.
Bauman DR; Steckelbroeck S; Williams MV; Peehl DM; Penning TM
Mol Endocrinol; 2006 Feb; 20(2):444-58. PubMed ID: 16179381
[TBL] [Abstract][Full Text] [Related]
5. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
6. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
[TBL] [Abstract][Full Text] [Related]
7. Dihydrotestosterone synthesis pathways from inactive androgen 5α-androstane-3β,17β-diol in prostate cancer cells: Inhibition of intratumoural 3β-hydroxysteroid dehydrogenase activities by abiraterone.
Ando T; Nishiyama T; Takizawa I; Ishizaki F; Miyashiro Y; Takeda K; Hara N; Tomita Y
Sci Rep; 2016 Aug; 6():32198. PubMed ID: 27561382
[TBL] [Abstract][Full Text] [Related]
8. Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer.
Ishizaki F; Nishiyama T; Kawasaki T; Miyashiro Y; Hara N; Takizawa I; Naito M; Takahashi K
Sci Rep; 2013; 3():1528. PubMed ID: 23524847
[TBL] [Abstract][Full Text] [Related]
9. Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.
Mohler JL; Titus MA; Bai S; Kennerley BJ; Lih FB; Tomer KB; Wilson EM
Cancer Res; 2011 Feb; 71(4):1486-96. PubMed ID: 21303972
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
Chen J; Wang WQ; Lin SX
J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
[TBL] [Abstract][Full Text] [Related]
11. 5alpha-Androstane-3alpha,17beta-diol activates pathway that resembles the epidermal growth factor responsive pathways in stimulating human prostate cancer LNCaP cell proliferation.
Zimmerman RA; Dozmorov I; Nunlist EH; Tang Y; Li X; Cowan R; Centola M; Frank MB; Culkin DJ; Lin HK
Prostate Cancer Prostatic Dis; 2004; 7(4):364-74. PubMed ID: 15452555
[TBL] [Abstract][Full Text] [Related]
12. A neuroactive steroid 5alpha-androstane-3alpha,17beta-diol regulates androgen receptor level in astrocytes.
Agapova OA; Malone PE; Hernandez MR
J Neurochem; 2006 Jul; 98(2):355-63. PubMed ID: 16638015
[TBL] [Abstract][Full Text] [Related]
13. Tissue androgen concentrations in golden hamsters with benign prostatic tumours.
Finney RW; Harper ME; Gaskell SJ; Griffiths K
J Endocrinol; 1980 Mar; 84(3):353-61. PubMed ID: 6156223
[TBL] [Abstract][Full Text] [Related]
14. Rapid and intensive conversion of 5alpha-androstane-3alpha, 17beta-diol into 5alpha-dihydrotestosterone in the male rat anterior pituitary: in vivo and in vitro studies.
Pilven A; Thieulant ML; Ducouret B; Sampérez S; Jouan P
Steroids; 1976 Sep; 28(3):349-58. PubMed ID: 982493
[TBL] [Abstract][Full Text] [Related]
15. Transition from androgenic to neurosteroidal action of 5α-androstane-3α, 17β-diol through the type A γ-aminobutyric acid receptor in prostate cancer progression.
Xia D; Lai DV; Wu W; Webb ZD; Yang Q; Zhao L; Yu Z; Thorpe JE; Disch BC; Ihnat MA; Jayaraman M; Dhanasekaran DN; Stratton KL; Cookson MS; Fung KM; Lin HK
J Steroid Biochem Mol Biol; 2018 Apr; 178():89-98. PubMed ID: 29155210
[TBL] [Abstract][Full Text] [Related]
16. Binding and metabolism of 5alpha-androstane-3alpha, 17 beta-diol and of 5alpha-androstane-3beta, 17 beta-diol in the prostate, seminal vesicles and plasma of male rats: studies in vivo and in vitro.
Krieg M; Horst HJ; Sterba ML
J Endocrinol; 1975 Mar; 64(3):529-38. PubMed ID: 1133541
[TBL] [Abstract][Full Text] [Related]
17. In vivo uptake and metabolism of 3-h-5alpha-androstane-3alpha,17beta-diol and of 3-h-5alpha-androstane-3beta,17beta-diol by human prostatic hypertrophy.
Horst HJ; Dennis M; Kaufmann J; Voigt KD
Acta Endocrinol (Copenh); 1975 Jun; 79(2):394-402. PubMed ID: 49141
[TBL] [Abstract][Full Text] [Related]
18. Dissection of the physiological interconversion of 5alpha-DHT and 3alpha-diol by rat 3alpha-HSD via transient kinetics shows that the chemical step is rate-determining: effect of mutating cofactor and substrate-binding pocket residues on catalysis.
Heredia VV; Penning TM
Biochemistry; 2004 Sep; 43(38):12028-37. PubMed ID: 15379543
[TBL] [Abstract][Full Text] [Related]
19. The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype.
Guerini V; Sau D; Scaccianoce E; Rusmini P; Ciana P; Maggi A; Martini PG; Katzenellenbogen BS; Martini L; Motta M; Poletti A
Cancer Res; 2005 Jun; 65(12):5445-53. PubMed ID: 15958594
[TBL] [Abstract][Full Text] [Related]
20. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
Pérez-Palacios G; Santillán R; García-Becerra R; Borja-Cacho E; Larrea F; Damián-Matsumura P; González L; Lemus AE
J Endocrinol; 2006 Sep; 190(3):805-18. PubMed ID: 17003281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
